Search

Balanites aegyptiaca is a wild plant species largely used in folk medicine and a priority fruit tree in West Africa. In Benin, its overexploitation for ethnoveterinary uses could lead to its rarity or extinction in the long term. In this study, we evaluate the possibilities of its substitution by other Zygophyllaceae species. This study was based on optimal defense theory, which distinguished 2 categories of plants: K-strategist species and r-strategist species. Phytochemical screening was carried out based on aqueous extracts of the leafy stems of B. aegyptiaca and Guaiacum officinale (K-strategist species) and Tribulus terrestris and Kallstroemia pubescens (r-strategist species) for the identification of chemical compounds. The phenolic compounds were quantified by quercetin and vanillin methods. The extracts were tested against 5 bacterial strains responsible for severe diarrhea in bovines. Our results indicated the presence of many phytochemicals, such as alkaloids, flavonoids, saponosides, and tannins. The diversity in secondary metabolites is higher for r-strategist than K-strategist species. The contents of total polyphenols ranged from 4.82 ± 0.05 to 41.84 mg GAE/g of extract. The flavonoid contents varied from 30.64 ± 0.35 to 57.11 ± 0.13 mg QE/g of extract and those of the tannins from 0.04 ± 0.00 to 0.06 ± 0.01 mg PE/mL. The sensitivity of the bacterial strains showed a significant dependence on the extracts. Of the species, K. pubescens showed a bactericidal activity on the majority of strains tested and thus could be a potential substitute for B. aegyptiaca in the treatment of infectious diarrhea. [ABSTRACT FROM AUTHOR]

Diabetes mellitus is one of the major health problems in Africa. The conventional oral synthetic antidiabetic drugs available to manage the disease are costly and not readily affordable to the majority of the affected population. Interestingly, the continent is endowed with a tremendous number of medicinal plants that have been explored for their folkloric treatment of diabetes mellitus. Scientific investigations have validated the antidiabetic potentials of a number of these medicinal plants but there is no repository with information on these scientifically investigated plants as a guide for future research. In this review article, all of the in vivo antidiabetic studies conducted between January 2000 and July 2013 on African plants are systematically compiled with a closer look at some relevant plants from the continent's subregions. Plants of the Asteraceae and Lamiaceae families are the most investigated, and West Africa has the highest number of investigated plants. Although promising results were reported in many cases, unfortunately, only a few studies reported the partial characterization of bioactive principles and/or mechanisms of action. It is hoped that government agencies, pharmaceutical industries, and the scientific community will have a look at some of these plants for future research and, if possible, subsequent commercialization. [ABSTRACT FROM AUTHOR]

The rapidly increasing incidence of diabetes mellitus is becoming a serious threat to mankind's health in all parts of the world. In fact, known cases reflect only part of the problem, as many diabetics, especially with type 2 diabetes, are unaware of their disease, which initially shows no definitive symptoms. Despite the great efforts invested in diabetes research, its prevalence continues to grow, while current medications do not cover all of the symptoms and complications of the disease. The present review highlights a plethora of studies focusing on the antidiabetic properties of desert and semidesert (steppic) plants, many of them being used for centuries in traditional medicine by Bedouins living in the arid zones of the Middle East and also by ethnic groups in other arid and semiarid parts of the world. The review concludes in summarizing the work done on the subject and also in pointing to the yet existing gaps in diabetes research of desert and steppic plants, and suggests directions for future exploration. [ABSTRACT FROM AUTHOR]

The article evaluates the stratum corneum flax seed extract from International Specialty Products Inc. (ISP).